MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2017 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
123 M |
Marktkapitalisierung |
$ 3.56 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
CEL-SCI Corporation
CVM
|
$ 1.79 | 2.87 % | $ 14.3 M | NYSE American,SPB | USA |
 |
Gilead Sciences
GILD
|
$ 156.19 | 2.49 % | $ 194 B | Nasdaq Global Select Market,SPB | USA |
 |
Hutchison China MediTech Limited
HCM
|
$ 14.05 | 0.79 % | $ 12.1 B | Nasdaq Global Select Market |  China |
 |
Entera Bio Ltd.
ENTX
|
$ 2.68 | 10.8 % | $ 124 M | Nasdaq Capital Market |  Israel |
 |
Sol-Gel Technologies Ltd.
SLGL
|
$ 64.25 | 0.72 % | $ 179 M | Nasdaq Global Select Market | Israel |
 |
Silence Therapeutics plc
SLN
|
$ 8.68 | 4.12 % | $ 1.23 B | Nasdaq Global Select Market |  Britain |
 |
Evogene Ltd.
EVGN
|
$ 0.39 | 0.03 % | $ 3.07 M | Nasdaq Global Market | Israel |
 |
Sanofi
SNY
|
$ 40.61 | 0.79 % | $ 49.6 B | Nasdaq Global Select Market |  France |
 |
Spruce Biosciences
SPRB
|
$ 39.65 | 6.39 % | $ 30.4 M | Nasdaq Global Select Market | USA |
 |
Spero Therapeutics
SPRO
|
$ 1.1 | 0.88 % | $ 61.6 M | Nasdaq Global Select Market | USA |
 |
Fate Therapeutics
FATE
|
$ 1.79 | 0.21 % | $ 213 M | Nasdaq Global Market,SPB | USA |
 |
Sutro Biopharma
STRO
|
$ 10.94 | 8.94 % | $ 93 M | Nasdaq Global Select Market | USA |
 |
Shattuck Labs
STTK
|
$ 5.42 | 3.75 % | $ 377 M | Nasdaq Global Select Market | USA |
 |
Daré Bioscience
DARE
|
$ 0.72 | 1.51 % | $ 8.05 M | Nasdaq Capital Market | USA |
 |
Savara
SVRA
|
$ 4.45 | 0.53 % | $ 990 M | Nasdaq Global Select Market | USA |
 |
China SXT Pharmaceuticals
SXTC
|
$ 0.07 | 0.15 % | $ 47.6 K | Nasdaq Global Select Market | China |
 |
Tarsus Pharmaceuticals
TARS
|
$ 68.07 | 0.9 % | $ 2.84 B | Nasdaq Global Select Market | USA |
 |
Anavex Life Sciences Corp.
AVXL
|
$ 1.31 | 1.01 % | $ 112 M | Nasdaq Capital Market | USA |
 |
Syros Pharmaceuticals
SYRS
|
- | -8.44 % | $ 3.4 M | Nasdaq Global Select Market | USA |
 |
Bio-Techne Corporation
TECH
|
$ 72.57 | 0.07 % | $ 11.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Tenax Therapeutics
TENX
|
$ 1.36 | 0.65 % | $ 53.3 M | Nasdaq Global Select Market | USA |
 |
Teva Pharmaceutical Industries Limited
TEVA
|
$ 41.5 | 0.95 % | $ 47.5 B | NYSE | Israel |
 |
TG Therapeutics
TGTX
|
$ 53.97 | 3.0 % | $ 7.79 B | Nasdaq Capital Market | USA |
 |
Gossamer Bio
GOSS
|
$ 8.77 | 0.11 % | $ 2 B | Nasdaq Global Select Market,SPB | USA |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
$ 6.04 | 0.31 % | $ 51.4 M | Nasdaq Global Select Market | USA |
 |
Trevi Therapeutics
TRVI
|
$ 11.88 | 0.41 % | $ 1.6 B | Nasdaq Global Market | USA |
 |
Gamida Cell Ltd.
GMDA
|
- | -18.25 % | $ 5.04 M | Nasdaq Global Market | Israel |
 |
Taysha Gene Therapies
TSHA
|
$ 3.62 | 6.27 % | $ 1.16 B | Nasdaq Global Select Market | USA |
 |
Innoviva
INVA
|
$ 20.78 | 0.19 % | $ 1.4 B | Nasdaq Global Select Market | USA |
 |
UroGen Pharma Ltd.
URGN
|
$ 34.56 | 0.08 % | $ 1.66 B | Nasdaq Global Select Market | Israel |
 |
United Therapeutics Corporation
UTHR
|
$ 533.12 | 0.27 % | $ 23.6 B | Nasdaq Global Select Market,SPB | USA |
|
Enlivex Therapeutics Ltd.
ENLV
|
$ 0.21 | 0.4 % | $ 9.6 M | Nasdaq Capital Market | Israel |
 |
Aridis Pharmaceuticals
ARDS
|
- | 17.91 % | $ 11.1 M | Nasdaq Capital Market | USA |
 |
Vericel Corporation
VCEL
|
$ 40.13 | 0.33 % | $ 2.02 B | Nasdaq Global Select Market,SPB | USA |
 |
Veracyte
VCYT
|
$ 43.12 | 1.16 % | $ 3.39 B | Nasdaq Global Market,SPB | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
$ 3.5 | 4.72 % | $ 566 M | Nasdaq Global Select Market | USA |
 |
Vir Biotechnology
VIR
|
$ 9.96 | 0.58 % | $ 1.38 B | Nasdaq Global Select Market,SPB | USA |
 |
Viking Therapeutics
VKTX
|
$ 25.17 | 7.46 % | $ 2.84 B | Nasdaq Capital Market | USA |
 |
Vanda Pharmaceuticals
VNDA
|
$ 4.04 | 0.24 % | $ 238 M | Nasdaq Global Select Market,SPB | USA |
 |
Genmab A/S
GMAB
|
$ 37.0 | 0.33 % | $ 2.39 B | Nasdaq Global Select Market |  Danmark |
 |
Verrica Pharmaceuticals
VRCA
|
$ 3.6 | 0.79 % | $ 38.3 M | Nasdaq Global Market | USA |
 |
Viridian Therapeutics
VRDN
|
$ 19.03 | 0.92 % | $ 1.94 B | Nasdaq Capital Market | USA |
 |
Inventiva S.A.
IVA
|
$ 2.94 | 8.36 % | $ 176 M | Nasdaq Global Market | France |
 |
Citius Pharmaceuticals
CTXR
|
$ 0.46 | 0.02 % | $ 5.09 M | Nasdaq Capital Market | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Bellerophon Therapeutics
BLPH
|
- | -74.18 % | $ 955 K | Nasdaq Capital Market | USA |
 |
Verastem
VSTM
|
$ 8.65 | 0.05 % | $ 600 M | Nasdaq Global Market | USA |
 |
VistaGen Therapeutics
VTGN
|
$ 0.2 | 3.1 % | $ 7.61 M | Nasdaq Global Select Market | USA |
 |
vTv Therapeutics
VTVT
|
$ 26.54 | 0.25 % | $ 105 M | Nasdaq Global Select Market | USA |
 |
Voyager Therapeutics
VYGR
|
$ 1.9 | 2.49 % | $ 112 M | Nasdaq Global Select Market | USA |